SOW
KRYS icon

State of Wyoming’s Krystal Biotech KRYS Stock Holding History

State of Wyoming’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-69
Closed -$5K – 1735
2022
Q2 		$5K Sell
69
-688
-91% -$42.8K ﹤0.01% 1721
2022
Q1 		$50K Buy
757
+244
+48% +$15.2K 0.03% 1056
2021
Q4 		$36K Buy
513
+74
+17% +$4.31K 0.02% 1257
2021
Q3 		$23K Sell
439
-256
-37% -$15.2K 0.01% 915
2021
Q2 		$47K Buy
695
+465
+202% +$32.5K 0.03% 763
2021
Q1 		$18K Buy
+230
New +$16.7K 0.03% 330

Other funds holding KRYS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return

State of Wyoming's KRYS Position: Q3 2022 in Review

State of Wyoming sold out of Krystal Biotech (KRYS) in Q3 2022, closing a stake of 69 shares — an estimated $5K sold.

State of Wyoming first reported a position in KRYS in Q1 2021 and held it in 6 quarters. The position peaked at $50K in Q1 2022. 148 funds tracked by Wall St. Rank hold KRYS as of Q3 2022.

  • State of Wyoming reported no remaining Krystal Biotech position as of Q3 2022 after selling out during the quarter.
  • State of Wyoming sold 69 Krystal Biotech shares in Q3 2022, an estimated $5K.
  • State of Wyoming first reported a position in Krystal Biotech in Q1 2021 and held it in 6 quarters.
  • State of Wyoming's Krystal Biotech position peaked at $50K in Q1 2022.
  • 148 funds tracked by Wall St. Rank held Krystal Biotech as of Q3 2022.

Based on State of Wyoming's 13F filing for Q3 2022, filed 14 Nov 2022.